Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History MLAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics MLAB

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

192.06 %
Forward Annual Dividend Yield 0.65 %
Consecutive Years 0
Forward Annual Dividend 0.64 USD
Consistent Years 17
Dividend CAGR 3Y
Continuous Dividends 21
Dividend CAGR 5Y
Payout Ratio TTM 23.81 %
Dividend CAGR 10Y 0.48 %
Ex Dividend Date 30.05.2025

Mesa Laboratories Inc

MLAB
Current price
97.91 USD +2.75 USD (+2.89%)
Last closed 95.82 USD
ISIN US59064R1095
Sector Technology
Industry Scientific & Technical Instruments
Exchange NASDAQ
Capitalization 522 740 256 USD
Yield for 12 month +7.42 %
1Y
3Y
5Y
10Y
15Y
MLAB
21.11.2021 - 28.11.2021

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado. Address: 12100 West Sixth Avenue, Lakewood, CO, United States, 80228

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

121.67 USD

P/E ratio

Dividend Yield

0.65 %

Financials MLAB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures MLAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+240 978 000 USD

Last Year

+216 187 000 USD

Current Quarter

+62 135 000 USD

Last Quarter

+62 840 000 USD

Current Year

+150 870 000 USD

Last Year

+133 250 000 USD

Current Quarter

+38 412 000 USD

Last Quarter

+39 754 000 USD
EBITDA 42 095 000 USD
Operating Margin TTM 2.36 %
Price to Earnings
Return On Assets TTM 2.50 %
PEG Ratio
Return On Equity TTM -1.29 %
Wall Street Target Price 121.67 USD
Revenue TTM 240 978 000 USD
Book Value 29.30 USD
Revenue Per Share TTM
Dividend Share 0.64 USD
Quarterly Revenue Growth YOY 5.50 %
Dividend Yield 0.65 %
Gross Profit TTM 152 102 000 USD
Earnings per share -0.36 USD
Diluted Eps TTM -0.36 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 387.50 %
Profit Margin -0.82 %

Stock Valuation MLAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 35.21
Enterprise Value Revenue 2.74
Price Sales TTM 2.11
Enterprise Value EBITDA 15.62
Price Book MRQ 3.17

Technical indicators MLAB

For 52 weeks

83.24 USD 154.70 USD
50 Day MA 111.04 USD
Shares Short Prior Month 185 209
200 Day MA 123.70 USD
Short Ratio 4.64
Shares Short 183 161
Short Percent 4.88 %